Tagrisso Tablets Clinical Experience Investigation (All case investigation)

Study identifier:D5160C00025

ClinicalTrials.gov identifier:NCT02756039

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Tagrisso Tablets Clinical Experience Investigation (All case investigation)

Medical condition

All patients treated with the product

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

3494

Study type

Observational

Age

N/A

Date

Study Start Date: 25 May 2016
Primary Completion Date: 31 Aug 2018
Study Completion Date: 31 Aug 2018

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2020 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria